BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) shot up 1.2% on Monday . The company traded as high as $0.9693 and last traded at $0.9693. Approximately 176 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 373,736 shares. The stock had previously closed at $0.9576.
BioPharma Credit Price Performance
The company has a 50-day moving average price of $0.96 and a 200-day moving average price of $0.92.
BioPharma Credit Company Profile
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Recommended Stories
- Five stocks we like better than BioPharma Credit
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
